pirazolac

SummaryThe absorption, disposition, biotransformation and excretion of the nonsteroidal anti-inflammatory drug pirazolac were… Expand

Bisphosphonates (BP) represent a class of compounds, all of which exhibit a strong affinity to the hydroxyapatite of bone tissue… Expand

The compounds 1,3,5-triphenyl-4,5-dihydro pyrazole, 1,3-diphenyl-5(p-methoxy phenyl)-4,5-dihydro pyrazole and 1,3-diphenyl-5(p… Expand

A 12-week trial was carried out to compare the efficacy of pirazolac (300-600 mg b.i.d.) with that of indomethacin (25-50 mg t.i… Expand

Pirazolac (PAA) is a new non-steroidal anti-inflammatory drug (NSAID) belonging to the subgroup of heterocyclic acetic acids. PAA… Expand

Six patients suffering from rheumatoid arthritis with massive knee joint effusions were treated with single daily doses of 600 mg… Expand

SummaryFollowing a washout period of 7 days, twenty-one patients suffering from rheumatoid arthritis and 3 from osteo-arthritis… Expand

The concentration-time course of pirazolac in plasma and its urinary excretion were investigated in 6 young volunteers (3 males… Expand

A study was carried out in 10 healthy subjects to compare the faecal blood loss caused by pirazolac, a new non-steroidal anti… Expand

Twenty-four patients with classical or definite rheumatoid arthritis participated in a 4-week double-blind crossover study to… Expand